October 21, 2014: Foster City, Calif.-based Gilead Sciences announced today it has broken ground on another R&D lab in Edmonton, Alberta’s Eco Industrial Park. This facility will be adjacent to existing facilities, including a laboratory that is nearing completion.
October 21, 2014: Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland, reports Bloomberg.
October 21, 2014: Novartis has won a stamp of approval for its pioneering psoriasis drug secukinumab after the Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S. Food and Drug Administration said late Monday that the benefits to patients are undeniable.
October 21, 2014: Here's BioSpace's guide to who's working on therapeutics or vaccines for Ebola and how those pipelines are progressing. Companies that are not included in the list but are also developing Ebola treatments are encouraged to contact BioSpace.